1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. SpineGuard
  6. News
  7. Summary
    ALSGD   FR0011464452

SPINEGUARD

(ALSGD)
Real-time Euronext Paris  -  11:35 2022-08-18 am EDT
0.6355 EUR   -1.93%
08/02SPINEGUARD : announces the revision of its 2022 financial calendar
PU
08/02SPINEGUARD : Provisional calendar
CO
07/1313 JULY 2022 – 12H00 CET : SpineGuard morning note by BioStrategic Research (in english) (Download PDF)
PU
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

SpineGuard Signs Three-year Collaboration To Add Ultrasound To Dynamic Surgical Guidance Robot

06/08/2022 | 01:12am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
CORECARD CORPORATION 0.91% 24.5 Delayed Quote.-37.42%
SPINEGUARD -1.93% 0.6355 Real-time Quote.-42.86%
All news about SPINEGUARD
08/02SPINEGUARD : announces the revision of its 2022 financial calendar
PU
08/02SPINEGUARD : Provisional calendar
CO
07/1313 JULY 2022 – 12H00 CET : SpineGuard morning note by BioStrategic Research (in engl..
PU
07/12SPINEGUARD : posts 20% revenue growth in Q2-2022
PU
07/12SpineGuard Reports Consolidated Revenue Results for the Second Quarter and First Half o..
CI
07/12SPINEGUARD : 2nd quarter earnings
CO
06/3030 JUNE 2022 – 18H00 CET : Assemblée générale du 30 juin 2022 – Compte rendu (..
PU
06/30SPINEGUARD : Proxy Statments
CO
06/0808 JUNE 2022 – 18H00 CET : Assemblée générale du 8 juin 2022 – 2ème avis de co..
PU
06/08SpineGuard Signs Three-year Collaboration To Add Ultrasound To Dynamic Surgical Guidanc..
MT
More news
Financials
Sales 2021 4,41 M - -
Net income 2021 -1,72 M - -
Net cash 2021 0,41 M - -
P/E ratio 2021 -18,0x
Yield 2021 -
Capitalization 19,3 M 19,5 M -
EV / Sales 2020 5,73x
EV / Sales 2021 7,56x
Nbr of Employees 15
Free-Float 90,4%
Chart SPINEGUARD
Duration : Period :
SpineGuard Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SPINEGUARD
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Managers and Directors
Pierre Jérôme Chairman & Chief Executive Officer
Manuel Lanfossi Chief Financial & Administrative Officer
Thibault Chandanson Director-Research & Development
Maurice Bourlion Independent Director
Alexia Perouse Independent Director
Sector and Competitors
1st jan.Capi. (M$)
SPINEGUARD-42.86%20
SHOCKWAVE MEDICAL, INC.58.95%10 184
MASIMO CORPORATION-43.46%8 696
NOVOCURE LIMITED9.55%8 615
PENUMBRA, INC.-41.46%6 373
GETINGE AB-44.04%5 788